aidot

[View original text]

AIDOT (CEO Jae-hoon Jeong) announced that AIDOT will participate in the Valcolp Forum, a project under the World Health Organization (WHO).

The Valcolp Forum is a global project led by Professor Marc Arbyn to report the verification and comparison results of colposcopy with the participation of a group of globally 

recognized professional medical staff and centers of excellence in the field of cervical cancer and cervical intraepithelial tumor.

AIDOT decided to participate in the Valcolp forum project at the request of Professor Mark Arbyn and proposed 'Cerviray AI' at the forum which is a next-generation cervical cancer 

screening solution.

Cerviray is a cervical cancer remote diagnosis AI system developed by AIDOT, and is the world's first solution that combines AI with the VIA technique that morphologically determines whether or not there is an abnormality in the cervix. Through a joint study with Korea University Anam Hospital and Seoul National University Bundang Hospital Obstetrics and 

Gynecology, it demonstrated 93% sensitivity and 89% specificity.

Chan Hur, head of global sales and marketing team at AIDOT said, "We were able to become a member of WHO's big project through participation in the Valcolp forum. It will serve as an opportunity to introduce Cerviray to the world." 

Meanwhile, since its establishment in June 2014, AIDOT has been participating in various government projects and trying to prove its technological prowess, and has developed an 

AI-based cervical cancer reading system 'Cerviray A.I.'

01st. Dec. 2021. / Digital Chosun Ilbo / Reporter Jeong-hyun Song